Investment Portfolio
(UNAUDITED) | 01.31.2021
CARILLON EAGLE SMALL CAP GROWTH FUND
COMMON STOCKS - 98.8%	Shares		Value
Biotechnology - 17.3%
Amicus Therapeutics, Inc.*		1,284,895	$	24,297,364
Arrowhead Pharmaceuticals, Inc.*		425,090		32,804,195
Biohaven Pharmaceutical Holding Co., Ltd.*		265,694		22,642,443
Blueprint Medicines Corp.*		330,384		31,964,652
Bridgebio Pharma, Inc.*(a)		190,273		10,799,896
CareDx, Inc.*		221,413		16,922,596
Denali Therapeutics, Inc.*		209,850		14,374,725
Dicerna Pharmaceuticals, Inc.*		1,046,925		23,524,405
Emergent BioSolutions, Inc.*		293,226		31,331,198
Fate Therapeutics, Inc.*		190,482		17,263,384
Halozyme Therapeutics, Inc.*		1,066,979		50,777,531
Insmed, Inc.*		862,178		32,409,271
Invitae Corp.*		303,406		15,024,665
Karuna Therapeutics, Inc.*		183,606		18,219,223
Kodiak Sciences, Inc.*		160,775		20,307,490
Kura Oncology, Inc.*		557,986		16,711,681
Mirati Therapeutics, Inc.*		155,365		31,901,095
Natera, Inc.*		320,611		34,189,957
Novavax, Inc.*		90,011		19,887,030
PTC Therapeutics, Inc.*		296,107		17,120,907
TG Therapeutics, Inc.*		496,327		23,957,704
Turning Point Therapeutics, Inc.*		269,743		33,850,049
Ultragenyx Pharmaceutical, Inc.*		202,025		27,998,645
Building products - 1.2%
Trex Co., Inc.*		417,699		38,332,237
Capital markets - 2.2%
LPL Financial Holdings, Inc.		290,830		31,508,522
PJT Partners, Inc., Class A		591,708		40,821,935
Chemicals - 3.1%
Quaker Chemical Corp.		385,218		100,977,194
Commercial services & supplies - 4.1%
Casella Waste Systems, Inc., Class A*		125,000		7,155,000
IAA, Inc.*		512,011		29,256,309
MSA Safety, Inc.		126,334		19,723,264
Ritchie Bros Auctioneers, Inc.		1,058,422		62,351,640
The Brink's Co.		240,742		16,401,752
Communications equipment - 1.4%
Lumentum Holdings, Inc.*		474,563		44,514,009
Construction materials - 1.4%
Summit Materials, Inc., Class A*		2,180,026		44,755,934
Distributors - 1.0%
Pool Corp.		97,674		34,594,177
Diversified consumer services - 1.5%
Chegg, Inc.*		503,120		47,927,211
Electrical equipment - 2.0%
Plug Power, Inc.*		685,246		43,286,990
Thermon Group Holdings, Inc.*		1,616,313		23,582,007
Electronic equipment, instruments & components - 2.9%
Cognex Corp.		476,084		39,100,779
II-VI, Inc.*		650,000		54,645,500
Equity real estate investment trusts (REITs) - 0.9%
EastGroup Properties, Inc.		214,057		28,927,663
Food & staples retailing - 1.8%
Casey's General Stores, Inc.		141,389		26,507,610
Grocery Outlet Holding Corp.*		763,367		32,588,137
Food products - 1.0%
The Simply Good Foods Co.*		1,130,857		32,274,659
Health care equipment & supplies - 4.1%
AtriCure, Inc.*		588,551		34,271,325
CONMED Corp.		319,938		35,801,062
CryoPort, Inc.*		320,149		21,834,162
iRhythm Technologies, Inc.*		62,959		10,603,555
Nevro Corp.*		188,585		30,511,167
Health care providers & services - 2.1%
AdaptHealth Corp.*		467,285		17,882,997
LHC Group, Inc.*		129,114		25,722,091
Progyny, Inc.*		534,539		25,000,389
Health care technology - 2.7%
Certara, Inc.*		394,274		13,570,911
Evolent Health, Inc., Class A*		2,143,756		36,593,915
Inspire Medical Systems, Inc.*		138,839		27,977,447
Omnicell, Inc.*		85,888		10,117,606
Hotels, restaurants & leisure - 8.7%
DraftKings, Inc., Class A*		692,544		37,473,556
Everi Holdings, Inc.*		3,976,860		52,017,329
Norwegian Cruise Line Holdings Ltd.*		1,250,131		28,315,467
Penn National Gaming, Inc.*		608,786		63,143,284
Planet Fitness, Inc., Class A*		491,550		35,391,600
Rush Street Interactive, Inc.*(a)		1,340,649		24,359,592
Wingstop, Inc.		306,777		46,031,889
Household durables - 2.0%
Universal Electronics, Inc.*(b)		1,183,472		64,191,521
Insurance - 1.9%
Kinsale Capital Group, Inc.		145,738		27,334,619
Palomar Holdings, Inc.*		186,518		18,575,328
Selectquote, Inc.*		801,064		16,918,472
IT services - 1.5%
EVO Payments, Inc., Class A*		1,124,737		25,823,962
Sabre Corp.		2,089,825		22,528,313
Life sciences tools & services - 3.9%
Medpace Holdings, Inc.*		196,761		26,127,893
NanoString Technologies, Inc.*		249,578		17,477,947
NeoGenomics, Inc.*		800,059		42,419,128
Pacific Biosciences of California, Inc.*		477,184		15,436,903
Repligen Corp.*		139,509		27,901,800
Machinery - 6.0%
Chart Industries, Inc.*		558,383		67,067,382
Desktop Metal, Inc., Class A*(a)		766,758		17,612,431
Graco, Inc.		393,699		27,141,609
John Bean Technologies Corp.		279,118		32,344,194
Woodward, Inc.		473,103		52,963,881
Oil, gas & consumable fuels - 0.8%
Viper Energy Partners LP		1,913,390		26,289,979
Pharmaceuticals - 1.6%
Arvinas, Inc.*		227,923		17,194,511
Horizon Therapeutics PLC*		477,856		34,635,003
Road & rail - 2.2%
Landstar System, Inc.		513,674		71,606,156
Semiconductors & semiconductor equipment - 6.0%
CMC Materials, Inc.		240,836		35,477,551
Entegris, Inc.		1,008,939		99,269,508
Lattice Semiconductor Corp.*		559,700		22,449,567
Silicon Laboratories, Inc.*		306,961		40,264,075
Software - 10.9%
Everbridge, Inc.*		355,106		47,204,241
Medallia, Inc.*		620,196		25,738,134
Pegasystems, Inc.		833,111		106,179,997
Proofpoint, Inc.*		237,463		30,651,724
PROS Holdings, Inc.*		454,388		19,147,910
Q2 Holdings, Inc.*		275,000		35,197,250
RealPage, Inc.*		861,036		74,539,887
Sumo Logic, Inc.*(a)		539,150		18,552,151
Specialty retail - 2.6%
Floor & Decor Holdings, Inc., Class A*		413,488		38,069,840
MarineMax, Inc.*		1,100,565		46,036,634
Total common stocks (cost $1,900,494,042)				3,234,501,480
MONEY MARKET FUNDS - 1.6%
First American Government Obligations Fund - Class X, 0.04%#		53,328,686		53,328,686
Total money market funds (cost $53,328,686)				53,328,686
Total investment portfolio (cost $1,953,822,728) - 100.4%				3,287,830,166
Liabilities in excess of other assets - (0.4)%				(13,576,046	)
Total net assets - 100.0%			$	3,274,254,120

* Non-income producing security

(a) All or a portion of this security was on loan as of the date of this report. The total fair market value of loaned securities was $49,379,517 or 1.5% of net assets as of the date of this report.

(b) Affiliated issuer. For additional information, please refer to the Fund's most recent semiannual or annual report.

 # Annualized seven-day yield as of the date of this report. Investment made with cash collateral received for securities on loan.

Fair value measurements | The Fund utilizes a three-level hierarchy of inputs to establish a classification of fair value measurements. The three levels are defined as:

Level 1—Valuations based on unadjusted quoted prices for identical securities in active markets;

Level 2—Valuations based on inputs other than quoted prices that are observable, either directly or indirectly, including inputs in markets that are not considered active; and

Level 3—Valuations based on inputs that are unobservable and significant to the fair value measurement, and may include the Valuation Committee’s own assumptions on determining fair value of investments.

Inputs that are used in determining fair value of an investment may include price information, credit data, volatility statistics, and other factors. These inputs can be either observable or unobservable. The availability of observable inputs can vary between investments and is affected by various factors such as the type of investment and the volume and/or level of activity for that investment or similar investments in the marketplace. The inputs will be considered by the Valuation Committee, along with any other relevant factors in the calculation of an investment’s fair value. The Fund uses prices and inputs that are current as of the valuation date, which may include periods of market dislocations. During these periods, the availability of prices and inputs may be reduced for many investments. This condition could cause an investment to be reclassified between the various levels within the hierarchy. Investments falling into the Level 3 category may be classified as such due to a lack of market transparency and corroboration to support the quoted prices. Additionally, valuation models may be used as the pricing source for any remaining investments classified as Level 3. These models may rely on one or more significant unobservable inputs and/or significant assumptions by the Valuation Committee. Inputs used in valuations may include, but are not limited to, financial statement analysis, capital account balances, discount rates and estimated cash flows, and comparable entity data.

All investments are categorized as Level 1 as of the date of this report.

For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual report.

The Global Industry Classification Standard (GICS®) was developed by and/or is the exclusive property of Morgan Stanley Capital International, Inc. (“MSCI”) and Standard & Poor’s Financial Services LLC (“S&P”). GICS is a service mark of MSCI and S&P and has been licensed for use by U.S. Bancorp Fund Services, LLC.

Investments in Affiliates

(UNAUDITED) | 01.31.2021

An issuer in which a Fund's holdings represent 5% or more of the outstanding voting securities of the issuer is an "affiliated" issuer as defined in the 1940 Act. A schedule of Carillon Eagle Small Cap Growth Fund's investments in securities of affiliated issuers is set forth below:

	Value at 10/31/20		Purchases		Sales			Net Realized Gain (Loss)			Net Change in Unrealized Appreciation (Depreciation)		Value at 01/31/21		Dividend Income		Shares owned at 01/31/21
MarineMax, Inc.*	$	36,292,739	$	-	$	(4,191,193	)	$	2,053,701		$	11,881,387	$	46,036,634	$	-		1,100,565
Universal Electronics, Inc.		46,083,072		-		(3,032,250	)		(103,180	)		21,243,879		64,191,521		-		1,183,472
Total	$	82,375,811	$	-	$	(7,223,443	)	$	1,950,521		$	33,125,266	$	110,228,155	$	-
*This security is no longer an affiliate of the Fund as of the date of this report.